Skip to main content
Erschienen in: Indian Journal of Pediatrics 1/2022

27.07.2021 | COVID-19 | Original Article Zur Zeit gratis

Clinical Profile of COVID-19 Illness in Children—Experience from a Tertiary Care Hospital

verfasst von: Preeti Singh, Karanvir Attri, Deonath Mahto, Virendra Kumar, Dipti Kapoor, Anju Seth, Varinder Singh, Harish Pemde, Praveen Kumar, Ravitanaya Sodani, Ankita Goel

Erschienen in: Indian Journal of Pediatrics | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Objective

To detail clinical profile and outcome in children infected with SARS-CoV-2.

Methods

This retrospective study was undertaken at a tertiary care pediatric teaching hospital in Northern India. The data on clinical characteristics and outcome of children (< 18 y) with COVID-19 illness from April 2020–October 2020 were reviewed and analyzed.

Results

A total of 2919 children with suspected severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) illness were tested for novel COVID-19 virus in the flu emergency (n = 1744), severe acute respiratory infection (SARI) ward (n = 825), and non-COVID area (n = 350) of the hospital. 8.73% (255/2919) children tested positive for SARS-CoV-2 infection. Of the 255 positive cases, 144 (56.47%) were managed on an outpatient basis and 100 (59 boys) required admission in COVID ward. The mortality rate of patients with SARS-CoV-2 was 11.4% (29/255). Majority of children admitted with COVID-19 had severe to critical illness due to the presence of malnutrition and underlying comorbidities.

Conclusions

Children of all age groups were susceptible to COVID-19 illness with a slight male preponderance. Amongst infected, two-third were asymptomatic or had mild symptoms that required outpatient management and home isolation. The adverse outcomes were more commonly seen in infants and children > 10 y of age with malnutrition and comorbid illness.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan. China JAMA. 2020;323:1061–9.CrossRef Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan. China JAMA. 2020;323:1061–9.CrossRef
2.
Zurück zum Zitat Gupta N, Praharaj I, Bhatnagar T, et al. Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020. Indian J Med Res. 2020;151:236–40.CrossRef Gupta N, Praharaj I, Bhatnagar T, et al. Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020. Indian J Med Res. 2020;151:236–40.CrossRef
3.
Zurück zum Zitat Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus Disease 2019 case surveillance – United States, January 22–May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:759–65.CrossRef Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus Disease 2019 case surveillance – United States, January 22–May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:759–65.CrossRef
4.
Zurück zum Zitat Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID–19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. 2020;323:1239–42.CrossRef Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID–19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. 2020;323:1239–42.CrossRef
5.
Zurück zum Zitat Han MS, Choi EH, Chang SH, et al. Clinical Characteristics and Viral RNA Detection in Children with coronavirus disease 2019 in the Republic of Korea. JAMA Pediatr. 2021;175:73–80.CrossRef Han MS, Choi EH, Chang SH, et al. Clinical Characteristics and Viral RNA Detection in Children with coronavirus disease 2019 in the Republic of Korea. JAMA Pediatr. 2021;175:73–80.CrossRef
6.
Zurück zum Zitat Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145:e20200702.CrossRef Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145:e20200702.CrossRef
7.
Zurück zum Zitat Balasubramanian S, Nagendran TM, Ramachandran B, Ramanan AV. Hyper–inflammatory syndrome in a child with covid–19 treated successfully with intravenous immunoglobulin and tocilizumab. Indian Pediatr. 2020;57:681–3.CrossRef Balasubramanian S, Nagendran TM, Ramachandran B, Ramanan AV. Hyper–inflammatory syndrome in a child with covid–19 treated successfully with intravenous immunoglobulin and tocilizumab. Indian Pediatr. 2020;57:681–3.CrossRef
8.
Zurück zum Zitat Dhanalakshmi K, Venkataraman A, Balasubramanian S, et al. Epidemiological and clinical profile of pediatric inflammatory multisystem syndrome – temporally associated with SARS–CoV–2 (PIMS–TS) in Indian children. Indian Pediatr. 2020;57:1010–4.CrossRef Dhanalakshmi K, Venkataraman A, Balasubramanian S, et al. Epidemiological and clinical profile of pediatric inflammatory multisystem syndrome – temporally associated with SARS–CoV–2 (PIMS–TS) in Indian children. Indian Pediatr. 2020;57:1010–4.CrossRef
10.
Zurück zum Zitat Revised Guidelines on Clinical Management of COVID – 19 Government of India. Ministry of Health & Family Welfare Directorate General of Health Services (EMR Division). Revised Guidelines on Clinical Management of COVID – 19 Government of India. Ministry of Health & Family Welfare Directorate General of Health Services (EMR Division).
11.
Zurück zum Zitat Weiss SL, Peters MJ, Alhazzani W, et al. Surviving Sepsis campaign international guidelines for the management of septic shock and sepsis–associated organ dysfunction in children. PediatrCrit Care Med. 2020;21:e52–106.CrossRef Weiss SL, Peters MJ, Alhazzani W, et al. Surviving Sepsis campaign international guidelines for the management of septic shock and sepsis–associated organ dysfunction in children. PediatrCrit Care Med. 2020;21:e52–106.CrossRef
12.
Zurück zum Zitat Nakra NA, Blumberg DA, Herrera-Guerra A, Lakshminrusimha S. Multi–system inflammatory syndrome in children (MIS–C) following SARS–CoV–2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management. Children (Basel). 2020;7:69. Nakra NA, Blumberg DA, Herrera-Guerra A, Lakshminrusimha S. Multi–system inflammatory syndrome in children (MIS–C) following SARS–CoV–2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management. Children (Basel). 2020;7:69.
13.
14.
Zurück zum Zitat Choi S-H, Kim HW, Kang J–M, Kim DH, Cho EY. Epidemiology and clinical features of coronavirus disease, in children. Clin Exp Pediatr. 2019;2020(63):125–32. Choi S-H, Kim HW, Kang J–M, Kim DH, Cho EY. Epidemiology and clinical features of coronavirus disease, in children. Clin Exp Pediatr. 2019;2020(63):125–32.
15.
Zurück zum Zitat Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID–19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr. 2020;174:868–73.CrossRef Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID–19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr. 2020;174:868–73.CrossRef
16.
Zurück zum Zitat Liguoro I, Pilotto C, Bonanni M, et al. SARS–COV–2 infection in children and newborns: a systematic review. Eur J Pediatr. 2020;179:1029–46.CrossRef Liguoro I, Pilotto C, Bonanni M, et al. SARS–COV–2 infection in children and newborns: a systematic review. Eur J Pediatr. 2020;179:1029–46.CrossRef
17.
Zurück zum Zitat Banerjee S, Guha A, Das A, Nandi M, Mondal R. A Preliminary Report of COVID–19 in Children in India. Indian Pediatr. 2020;57:963–4.CrossRef Banerjee S, Guha A, Das A, Nandi M, Mondal R. A Preliminary Report of COVID–19 in Children in India. Indian Pediatr. 2020;57:963–4.CrossRef
18.
Zurück zum Zitat Lu X, Zhang L, Du H, et al. SARS–CoV–2 infection in children. N Engl J Med. 2020;382:1663–5.CrossRef Lu X, Zhang L, Du H, et al. SARS–CoV–2 infection in children. N Engl J Med. 2020;382:1663–5.CrossRef
19.
Zurück zum Zitat Meena J, Yadav J, Saini L, Yadav A, Kumar J. Clinical features and outcome of SARS–CoV–2 infection in children: a systematic review and meta–analysis. Indian Pediatr. 2020;57:820–6.CrossRef Meena J, Yadav J, Saini L, Yadav A, Kumar J. Clinical features and outcome of SARS–CoV–2 infection in children: a systematic review and meta–analysis. Indian Pediatr. 2020;57:820–6.CrossRef
20.
Zurück zum Zitat Hoang A, Chorath K, Moreira A, et al. COVID–19 in 7780 pediatric patients: a systematic review. Eclinical Medicine. 2020;24:100433.CrossRef Hoang A, Chorath K, Moreira A, et al. COVID–19 in 7780 pediatric patients: a systematic review. Eclinical Medicine. 2020;24:100433.CrossRef
21.
Zurück zum Zitat Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID–19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. 2020;20:689–96.CrossRef Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID–19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. 2020;20:689–96.CrossRef
22.
Zurück zum Zitat Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–13.CrossRef Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–13.CrossRef
23.
Zurück zum Zitat Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID–19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623.CrossRef Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID–19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623.CrossRef
24.
Zurück zum Zitat Patel NA. Pediatric COVID–19: a systematic review of the literature. Am J Otolaryngol. 2020;41:102573.CrossRef Patel NA. Pediatric COVID–19: a systematic review of the literature. Am J Otolaryngol. 2020;41:102573.CrossRef
25.
Zurück zum Zitat Acharyya BC, Acharyya S, Das D. Novel coronavirus, mimicking kawasaki disease in an infant. Indian Pediatr. 2020;57:753–4.CrossRef Acharyya BC, Acharyya S, Das D. Novel coronavirus, mimicking kawasaki disease in an infant. Indian Pediatr. 2020;57:753–4.CrossRef
26.
Zurück zum Zitat Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe kawasaki–like disease at the Italian epicentre of the SARS–CoV–2 epidemic: an observational cohort study. Lancet. 2020;395:1771–8.CrossRef Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe kawasaki–like disease at the Italian epicentre of the SARS–CoV–2 epidemic: an observational cohort study. Lancet. 2020;395:1771–8.CrossRef
27.
Zurück zum Zitat Viner RM, Whittaker E. Kawasaki–like disease: emerging complication during the COVID–19 pandemic. Lancet. 2020;395:1741–3.CrossRef Viner RM, Whittaker E. Kawasaki–like disease: emerging complication during the COVID–19 pandemic. Lancet. 2020;395:1741–3.CrossRef
Metadaten
Titel
Clinical Profile of COVID-19 Illness in Children—Experience from a Tertiary Care Hospital
verfasst von
Preeti Singh
Karanvir Attri
Deonath Mahto
Virendra Kumar
Dipti Kapoor
Anju Seth
Varinder Singh
Harish Pemde
Praveen Kumar
Ravitanaya Sodani
Ankita Goel
Publikationsdatum
27.07.2021
Verlag
Springer India
Schlagwort
COVID-19
Erschienen in
Indian Journal of Pediatrics / Ausgabe 1/2022
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-021-03822-5

Weitere Artikel der Ausgabe 1/2022

Indian Journal of Pediatrics 1/2022 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.